Given that EMT and PTEN downregulation are important in breast cancer stem cell (CSC) formation and drug resistance (Sun et al., 2016), we suspect that PRL-3 may promote the transition of cancer cells to CSCs. The gene discussed is PTP4A3; the disease is breast cancer.